156 related articles for article (PubMed ID: 35672787)
1. Automated whole-slide images assessment of immune infiltration in resected non-small-cell lung cancer: towards better risk-stratification.
Lin H; Pan X; Feng Z; Yan L; Hua J; Liang Y; Han C; Xu Z; Wang Y; Wu L; Cui Y; Huang X; Shi Z; Chen X; Chen X; Zhang Q; Liang C; Zhao K; Li Z; Liu Z
J Transl Med; 2022 Jun; 20(1):261. PubMed ID: 35672787
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
Front Immunol; 2022; 13():835630. PubMed ID: 35401554
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence-quantified tumour-lymphocyte spatial interaction predicts disease-free survival in resected lung adenocarcinoma: A graph-based, multicentre study.
Feng Z; Lin H; Liu Z; Yan L; Wang Y; Li B; Liu E; Han C; Shi Z; Lu C; Liu Z; Pang C; Li Z; Cui Y; Pan X; Chen X
Comput Methods Programs Biomed; 2023 Aug; 238():107617. PubMed ID: 37235970
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a computed tomography-based immune ecosystem diversity index as an imaging biomarker in non-small cell lung cancer.
He L; Li ZH; Yan LX; Chen X; Sanduleanu S; Zhong WZ; Lambin P; Ye ZX; Sun YS; Liu YL; Qu JR; Wu L; Tu CL; Scrivener M; Pieters T; Coche E; Yang Q; Yang M; Liang CH; Huang YQ; Liu ZY
Eur Radiol; 2022 Dec; 32(12):8726-8736. PubMed ID: 35639145
[TBL] [Abstract][Full Text] [Related]
5. Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer.
Bocchialini G; Lagrasta C; Madeddu D; Mazzaschi G; Marturano D; Sogni F; Silini EM; Gnetti L; Becchi G; Rusca M; Carbognani P; Ventura L; Braggio C; Tiseo M; Quaini F; Ampollini L
Eur J Cardiothorac Surg; 2020 Sep; 58(3):619-628. PubMed ID: 32267920
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence-based analysis of tumor-infiltrating lymphocyte spatial distribution for colorectal cancer prognosis.
Cai M; Zhao K; Wu L; Huang Y; Zhao M; Hu Q; Chen Q; Yao S; Li Z; Fan X; Liu Z
Chin Med J (Engl); 2024 Feb; 137(4):421-430. PubMed ID: 38238158
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
8. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
[TBL] [Abstract][Full Text] [Related]
9. Artificial intelligence-assisted analysis for tumor-immune interaction within the invasive margin of colorectal cancer.
Ye Y; Wu X; Wang H; Ye H; Zhao K; Yao S; Liu Z; Zhu Y; Zhang Q; Liang C
Ann Med; 2023 Dec; 55(1):2215541. PubMed ID: 37224471
[TBL] [Abstract][Full Text] [Related]
10. Low PD-1 Expression in Cytotoxic CD8
Mazzaschi G; Madeddu D; Falco A; Bocchialini G; Goldoni M; Sogni F; Armani G; Lagrasta CA; Lorusso B; Mangiaracina C; Vilella R; Frati C; Alfieri R; Ampollini L; Veneziani M; Silini EM; Ardizzoni A; Urbanek K; Aversa F; Quaini F; Tiseo M
Clin Cancer Res; 2018 Jan; 24(2):407-419. PubMed ID: 29074606
[No Abstract] [Full Text] [Related]
11. Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naive patients with advanced NSCLC.
Ying HQ; Liao YC; Luo YR; Xiong G; Huang Y; Nie RW; Xiong CF; Cheng XX
Pharmacol Res; 2021 Aug; 170():105734. PubMed ID: 34157424
[TBL] [Abstract][Full Text] [Related]
12. Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC.
Mazzaschi G; Milanese G; Pagano P; Madeddu D; Gnetti L; Trentini F; Falco A; Frati C; Lorusso B; Lagrasta C; Minari R; Ampollini L; Silva M; Sverzellati N; Quaini F; Roti G; Tiseo M
Lung Cancer; 2020 Jun; 144():30-39. PubMed ID: 32361033
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunoscore approach.
Feng W; Li Y; Shen L; Zhang Q; Cai XW; Zhu ZF; Sun MH; Chen HQ; Fu XL
Ther Adv Med Oncol; 2021; 13():1758835920984975. PubMed ID: 33488784
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
15. Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.
O'Callaghan DS; Rexhepaj E; Gately K; Coate L; Delaney D; O'Donnell DM; Kay E; O'Connell F; Gallagher WM; O'Byrne KJ
Eur Respir J; 2015 Dec; 46(6):1762-72. PubMed ID: 26541534
[TBL] [Abstract][Full Text] [Related]
16. Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy.
Althammer S; Tan TH; Spitzmüller A; Rognoni L; Wiestler T; Herz T; Widmaier M; Rebelatto MC; Kaplon H; Damotte D; Alifano M; Hammond SA; Dieu-Nosjean MC; Ranade K; Schmidt G; Higgs BW; Steele KE
J Immunother Cancer; 2019 May; 7(1):121. PubMed ID: 31060602
[TBL] [Abstract][Full Text] [Related]
17. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
[TBL] [Abstract][Full Text] [Related]
18. A deep learning quantified stroma-immune score to predict survival of patients with stage II-III colorectal cancer.
Xu Z; Li Y; Wang Y; Zhang S; Huang Y; Yao S; Han C; Pan X; Shi Z; Mao Y; Xu Y; Huang X; Lin H; Chen X; Liang C; Li Z; Zhao K; Zhang Q; Liu Z
Cancer Cell Int; 2021 Oct; 21(1):585. PubMed ID: 34717647
[TBL] [Abstract][Full Text] [Related]
19. High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer.
Massarelli E; Lam VK; Parra ER; Rodriguez-Canales J; Behrens C; Diao L; Wang J; Blando J; Byers LA; Yanamandra N; Brett S; Morley P; Sharma P; Allison J; Wistuba II; Heymach JV
J Immunother Cancer; 2019 Dec; 7(1):351. PubMed ID: 31843013
[TBL] [Abstract][Full Text] [Related]
20. Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer.
Zhao K; Li Z; Yao S; Wang Y; Wu X; Xu Z; Wu L; Huang Y; Liang C; Liu Z
EBioMedicine; 2020 Nov; 61():103054. PubMed ID: 33039706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]